FdaApplication
ANDA 208928
Identifiers
- fda_app_no: ANDA208928
Properties
| Property | Value |
|---|---|
| applicant_name | IPCA LABORATORIES LTD |
| application_type | ANDA |
| approval_date | 2023-11-20 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GABAPENTIN | GABAPENTIN | 100MG | CAPSULE;ORAL |
| GABAPENTIN | GABAPENTIN | 400MG | CAPSULE;ORAL |
| GABAPENTIN | GABAPENTIN | 300MG | CAPSULE;ORAL |
3 products